EUVIMEDEUVIMED entdecken
Open Access

IRF4 transcriptionally activates CD36 to regulate glycolysis and suppress oxaliplatin resistance in colorectal cancer

Qing Sun, Dongliang Zhao, Zhongcai Yao, Ruolin Sun, Yefei Zhang iD

The Korean Journal of Physiology & Pharmacology · 01.11.2026 · 30 (6) · 641-651

DOI: 10.4196/kjpp.25.448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Korean Journal of Physiology & Pharmacology, online erschienen am 02.07.2026. Verfasst von Qing Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroentero-anorectal Surgery, Zhuji Affiliated Hospital of Wenzhou Medical University, Shaoxing, Zhejiang 311800, China. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Shaoxing Municipal Health Science and Technology Plan Project, Shaoxing Basic Public Welfare Special Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CD36 proteinColorectal neoplasmsDrug resistanceGlycolysisInterferon regulatory factor-4

Autor:innen und Institutionen

  • Department of Gastroentero-anorectal Surgery, Zhuji Affiliated Hospital of Wenzhou Medical University, Shaoxing, Zhejiang 311800, China.
  • Department of Infectious Diseases, Zhuji Affiliated Hospital of Wenzhou Medical University, Shaoxing, Zhejiang 311800, China.
  • Hangzhou Medical College, Hangzhou, Zhejiang 310000, China.
  • Clinical Pharmaceutics Room, Zhuji Affiliated Hospital of Wenzhou Medical University, Zhuji, Shaoxing, Zhejiang 311800, China.

ORCID-Profile: Yefei Zhang

Förderung

  • Shaoxing Municipal Health Science and Technology Plan Project
  • Shaoxing Basic Public Welfare Special Project

Zitieren

APA

Sun, Q., Zhao, D., Yao, Z., Sun, R., & Zhang, Y. (2026). IRF4 transcriptionally activates CD36 to regulate glycolysis and suppress oxaliplatin resistance in colorectal cancer. The Korean Journal of Physiology & Pharmacology, 30(6), 641-651. https://doi.org/10.4196/kjpp.25.448

Vancouver

Sun Q, Zhao D, Yao Z, Sun R, Zhang Y. IRF4 transcriptionally activates CD36 to regulate glycolysis and suppress oxaliplatin resistance in colorectal cancer. The Korean Journal of Physiology & Pharmacology. 2026;30(6):641-651. doi:10.4196/kjpp.25.448

BibTeX
@article{Sun2026,
  author = {Sun, Qing and Zhao, Dongliang and Yao, Zhongcai and Sun, Ruolin and Zhang, Yefei},
  title = {IRF4 transcriptionally activates CD36 to regulate glycolysis and suppress oxaliplatin resistance in colorectal cancer},
  journal = {The Korean Journal of Physiology & Pharmacology},
  year = {2026},
  volume = {30},
  number = {6},
  pages = {641--651},
  doi = {10.4196/kjpp.25.448}
}
Kostenlos starten →